Morie Gertz, MD
Mayo Clinic
Rochester, MN, USA

Dr. Morie Gertz, thirty-year myeloma researcher and Chair of the Department of Medicine at the Mayo Clinic-Rochester, comments on breakthrough presentations from the 58th Annual American Society of Hematology meeting. In this video, he says, “This year’s ASH proves that we are moving very close to a cure for myeloma, having converted it to a chronic disease for which we should expect long-term survival for the majority of our patients.” 



Dr. Morie Gertz is a Hematologist/Oncologist and Chair of General Internal Medicine at the Mayo Clinic in Rochester, Minnesota. He treats both amyloidosis and multiple myeloma. Visit Dr. Morie Gertz’s full biography.

Previous Post
ASH 2016: Amyloidosis Overview
Next Post
ASH 2016: Multiple Myeloma Overview - Dr. Paul Richardson

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.